Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Clinical Pediatric Hematology-Oncology ; : 110-114, 2019.
Article in English | WPRIM | ID: wpr-763512

ABSTRACT

Hepatic osteodystrophy is frequent complication in patients with chronic liver disease, particularly with chronic cholestasis. We report a male infant with congenital hepatoblastoma, who had osteodystrophy complicated by multiple bone fractures despite adequate supplementation of fat-soluble vitamins including vitamin D. He was born by Caesarean section because of a 7 cm–sized abdominal mass detected by prenatal ultrasonography. The pathologic diagnosis was hepatoblastoma, PRETEXT staging III or IV. Whole body bone scan at the time of diagnosis showed no abnormal uptake. Oral vitamin D3 of 2,000 IU/day was administered with other fat-soluble vitamins. Serum direct bilirubin level gradually increased up to 28.9 mg/dL at postnatal 6 days and was above 5 mg/dL until 110 days of age. Bony changes consistent with rickets became apparent in left proximal humerus since 48 days of age, and multiple bone fractures developed thereafter. With resolving cholestasis by chemotherapy, his bony lesions improved gradually after add-on treatment of bisphosphonate and parenteral administration of vitamin D with calcium. High level of suspicion and prevention of osteodystrophy is needed in patients with hepatoblastoma, especially when cholestasis persists.


Subject(s)
Female , Humans , Infant , Male , Pregnancy , Bilirubin , Calcium , Cesarean Section , Cholecalciferol , Cholestasis , Diagnosis , Drug Therapy , Fractures, Bone , Hepatoblastoma , Humerus , Liver Diseases , Rickets , Ultrasonography, Prenatal , Vitamin D , Vitamins
2.
Korean Journal of Pediatric Hematology-Oncology ; : 120-124, 2005.
Article in Korean | WPRIM | ID: wpr-220860

ABSTRACT

Hepatoblastoma is the most common primary malignant hepatic tumor in infancy and childhood. But congenital hepatoblastomas are extremely rare and show distinctive, but important features when compared with tumors diagnosed in children beyond the neonatal age. They have different clinical presentations, higher incidence of pure fetal histology, significant risk for systemic metastasis, and worse outcome. The treatment of congenital hepatoblastoma should be the same as in older children, i.e., primary chemotherapy with delayed resection. We report a case of congenital hepatoblastoma in a 29-day-old boy who was known to have a well-defined ovoid hypoechoic mass at liver demonstrated by fetal sonography.


Subject(s)
Child , Humans , Male , Drug Therapy , Hepatoblastoma , Incidence , Liver , Neoplasm Metastasis
SELECTION OF CITATIONS
SEARCH DETAIL